@rbreich not to say Moderna does not do corporate greed, but it is misleading to compare production costs with sales price. The lion's share of the costs in pharma occurs in development phase, when thousands of researchers work on products or vaccines, more often than not leading to no marketable product at all. And there is still a little thing called competition. It is allowed for any other company to have their own qualitative vaccine approved and sell it cheaper.